Index S&P 500
P/E 24.60
EPS (ttm) 2.96
Insider Own 0.98%
Shs Outstand 129.25M
Perf Week 5.79%
Market Cap 9.35B
Forward P/E 13.00
EPS next Y 5.60
Insider Trans -6.41%
Shs Float 127.23M
Perf Month -0.55%
Income 388.00M
PEG 3.39
EPS next Q 1.25
Inst Own 98.58%
Short Float 4.12%
Perf Quarter -3.32%
Sales 12.45B
P/S 0.75
EPS this Y 12.69%
Inst Trans 0.51%
Short Ratio 4.52
Perf Half Y 16.18%
Book/sh 28.02
P/B 2.60
EPS next Y 10.37%
ROA 4.15%
Short Interest 5.24M
Perf Year -8.82%
Cash/sh 1.24
P/C 58.80
EPS next 5Y 7.25%
ROE 10.97%
52W Range 60.01 - 82.63
Perf YTD -3.89%
Dividend Est. -
P/FCF 19.77
EPS past 5Y -1.96%
ROI 6.60%
52W High -11.94%
Beta 0.91
Dividend TTM -
Quick Ratio 1.02
Sales past 5Y 5.89%
Gross Margin 29.56%
52W Low 21.25%
ATR (14) 1.74
Dividend Ex-Date -
Current Ratio 1.75
EPS Y/Y TTM -19.28%
Oper. Margin 5.63%
RSI (14) 55.10
Volatility 2.37% 2.03%
Employees 25000
Debt/Eq 0.76
Sales Y/Y TTM -0.61%
Profit Margin 3.12%
Recom 2.67
Target Price 79.86
Option/Short Yes / Yes
LT Debt/Eq 0.63
EPS Q/Q -21.21%
Payout 0.00%
Rel Volume 1.18
Prev Close 71.20
Sales Surprise -1.05%
EPS Surprise 8.23%
Sales Q/Q 3.66%
Earnings May 07 BMO
Avg Volume 1.16M
Price 72.76
SMA20 2.57%
SMA50 -0.50%
SMA200 -0.64%
Trades
Volume 1,328,653
Change 2.20%
Date
Action
Analyst
Rating Change
Price Target Change
Feb-26-24 Initiated
Leerink Partners
Market Perform
$78
Dec-12-23 Upgrade
JP Morgan
Neutral → Overweight
$71 → $82
Nov-10-23 Upgrade
Stifel
Hold → Buy
$70
Aug-08-22 Upgrade
UBS
Sell → Neutral
$80
Jul-21-22 Downgrade
Goldman
Buy → Neutral
$93 → $85
Jun-14-22 Downgrade
Robert W. Baird
Outperform → Neutral
$103 → $88
May-13-22 Resumed
Credit Suisse
Outperform
$100
Jan-31-22 Initiated
Morgan Stanley
Underweight
$67
Jan-07-22 Upgrade
Credit Suisse
Neutral → Outperform
$78 → $90
Oct-01-21 Resumed
Credit Suisse
Neutral
$78
Feb-08-21 Resumed
Piper Sandler
Overweight
$83
Jan-04-21 Upgrade
Robert W. Baird
Neutral → Outperform
$70 → $79
Nov-03-20 Upgrade
Barrington Research
Mkt Perform → Outperform
$72
May-06-20 Downgrade
Barrington Research
Outperform → Mkt Perform
Apr-07-20 Upgrade
Goldman
Neutral → Buy
$64 → $59
Apr-02-20 Upgrade
Wolfe Research
Peer Perform → Outperform
$68
Jan-09-20 Downgrade
BofA/Merrill
Neutral → Underperform
Jan-02-20 Upgrade
Evercore ISI
Underperform → In-line
$61 → $70
Aug-07-19 Downgrade
William Blair
Outperform → Mkt Perform
May-30-19 Initiated
Wolfe Research
Underperform
Show Previous Ratings
Today 12:54PM
10:23AM
09:40AM
07:40AM
06:19AM
03:28AM
Loading…
03:28AM
01:14AM
(Thomson Reuters StreetEvents)
May-07-24 10:55AM
09:30AM
08:58AM
08:06AM
07:32AM
07:10AM
06:38AM
06:09AM
(Associated Press Finance)
06:00AM
Loading…
06:00AM
May-02-24 09:15AM
Apr-29-24 06:30AM
Apr-23-24 06:30AM
Apr-22-24 08:42AM
06:30AM
Apr-18-24 06:30AM
Apr-17-24 11:07AM
07:46AM
Apr-11-24 06:30AM
Apr-10-24 04:05PM
Apr-05-24 07:17AM
Apr-04-24 06:30AM
Apr-02-24 10:13AM
08:01AM
05:34AM
Loading…
Apr-01-24 05:34AM
Mar-31-24 12:51AM
Mar-28-24 11:30AM
Mar-21-24 07:00PM
Mar-19-24 07:00PM
Mar-10-24 10:08AM
Mar-06-24 11:55PM
Mar-04-24 06:30AM
Feb-28-24 09:09AM
02:21AM
(Thomson Reuters StreetEvents)
Feb-27-24 09:30AM
08:44AM
07:32AM
07:10AM
06:32AM
06:18AM
(Associated Press Finance)
06:00AM
05:30AM
Feb-22-24 09:15AM
06:30AM
Feb-21-24 06:30AM
Feb-19-24 08:00AM
Feb-16-24 08:38AM
Feb-14-24 06:30AM
Feb-07-24 09:00AM
Feb-01-24 09:32AM
Jan-25-24 07:00AM
Jan-23-24 08:57AM
06:30AM
Jan-03-24 06:30AM
Dec-27-23 10:09AM
Dec-23-23 07:01PM
Dec-21-23 11:39AM
Dec-20-23 07:00AM
Dec-18-23 04:12PM
Dec-15-23 06:30AM
Dec-13-23 11:30AM
Dec-08-23 07:25AM
Dec-05-23 07:37AM
Dec-04-23 02:00AM
Dec-03-23 04:00PM
Nov-30-23 06:29AM
Nov-28-23 06:30AM
Nov-16-23 05:10PM
Nov-14-23 01:19PM
07:20AM
05:50AM
(Thomson Reuters StreetEvents)
Nov-13-23 05:25PM
04:50PM
03:56PM
12:37PM
10:59AM
09:30AM
07:15AM
07:00AM
06:58AM
06:07AM
(Associated Press Finance)
06:00AM
06:00AM
Nov-10-23 11:50AM
Nov-08-23 04:00PM
07:00AM
Nov-07-23 07:00AM
Nov-02-23 04:10PM
10:00AM
Oct-31-23 10:01AM
Oct-30-23 08:41AM
Oct-25-23 05:20AM
Oct-24-23 09:05AM
Oct-18-23 09:40AM
Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Connett Bradford C CEO, NA Distribution Group Mar 20 '24 Sale 74.28 6,430 477,620 73,108 Mar 21 04:18 PM BRESLAWSKI JAMES P Vice Chairman, President Mar 18 '24 Sale 74.37 2,907 216,194 209,562 Mar 19 04:11 PM LASKAWY PHILIP A Director Mar 05 '24 Sale 76.29 4,278 326,369 24,565 Mar 06 04:54 PM BRESLAWSKI JAMES P Vice Chairman, President Mar 04 '24 Sale 76.50 2,907 222,386 212,469 Mar 05 04:27 PM KUEHN KURT P Director Mar 01 '24 Sale 77.07 1,582 121,925 13,598 Mar 05 04:52 PM BERGMAN STANLEY M Chairman, CEO Dec 26 '23 Sale 75.14 13,962 1,049,105 168,633 Dec 27 04:10 PM BERGMAN STANLEY M Chairman, CEO Dec 26 '23 Sale 75.14 5,820 437,315 481,450 Dec 27 04:10 PM BERGMAN STANLEY M Chairman, CEO Dec 22 '23 Sale 75.03 26,190 1,965,036 182,595 Dec 27 04:10 PM BERGMAN STANLEY M Chairman, CEO Dec 22 '23 Sale 75.03 10,914 818,877 487,270 Dec 27 04:10 PM Connett Bradford C CEO, NA Distribution Group Dec 21 '23 Sale 74.02 11,238 831,837 57,831 Dec 22 04:02 PM Brous David B Jr CEO, Strategic Business Group Jun 12 '23 Sale 74.86 11,157 835,191 68,690 Jun 13 04:35 PM Siegel Walter Sr. VP & Chief Legal Officer Jun 05 '23 Sale 74.07 5,497 407,163 35,737 Jun 07 04:07 PM BRESLAWSKI JAMES P Vice Chairman, President Jun 02 '23 Sale 74.29 24,234 1,800,453 201,555 Jun 06 04:04 PM Ettinger Michael S EVP & Chief Operating Officer May 24 '23 Sale 75.12 14,881 1,117,861 75,710 May 25 04:48 PM MLOTEK MARK E EVP, Chief Strategic Officer May 19 '23 Sale 76.68 24,747 1,897,600 69,138 May 23 04:18 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite